bmiMD vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
bmiMD beats Hims overall, scoring 8/10 vs 7.9/10. Hims is more affordable at $175/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Hims for men who want glp-1 access from a well-known, publicly traded.
A side-by-side comparison of bmiMD and Hims covering pricing, scores, medication types, insurance, and more to help you decide.
bmiMD
#9 of 40Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDHims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit Hims| Feature | bmiMD | Hims |
|---|---|---|
| Our Score | 8/10 | 7.9/10 |
| Starting Price | $319/mo | $175/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-first users who want affordable GLP-1 access | Men who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #9 | #12 |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
- −$29.99 shipping fee per order — most competitors include free shipping
- −$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
bmiMD edges out Hims with a score of 8/10 vs 7.9/10. If budget is your priority, Hims starts at $175/mo compared to bmiMD's $319/mo. bmiMD offers both brand-name and compounded medications, giving you more flexibility. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand.